Amgen

World Rank (Jan-05-2024)

73

Market Cap (Jan-05-2024)

162.250 Billion USD

World Rank (Jul-30-2023)

105

Market Cap (Jul-30-2023)

126.300 Billion USD

World Rank (Jan-07-2022)

113

Market Cap (Jan-07-2022)

128.030 Billion USD

World Rank (Jan-01-2021)

91

Market Cap (Jan-01-2021)

133.850 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 63

Headquarters Country

USA

Nasdaq / NYSE Code

AMGN

Market Cap (Mar-08-2026)

199.20

CEO

Robert A. Bradway

Chairman

Robert A. Bradway

Founders

George Rathmann

Employee Count

25,200

Employee Count as of Date

As on Dec-2022

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

28,190 Million USD

Annual Operating Income in USD

7,897 Million USD

Annual Net Income in USD

6,717 Million USD

Annual Results for Period Ending

Dec-2023 ending year

Total Assets in USD

97,154 Million USD

Total Liabilities in USD

90,922 Million USD

Total Equity in USD

6,232 Million USD

Balance Sheet for Period Ending

Dec-2023 ending year

Business Sector

Company Website

Amgen Inc - Bio Technology Products Healthcare Company

Wikipedia

Yahoo

Yahoo @ Nasdaq

Company Profile

Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

Amgen believes in a “biology first” approach. Amgen use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Facts About Company

As on 2022, Amgen has 25,200 employees.

Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

Split of Annual Revenue by business segment for period ending Dec-2021:

Product sales: 24,297 million USD.
Other revenues : 1,682 million USD.

Amgen annual net income generated for period ending Dec-2021 was 5,893 million USD.

Annual Results Summary

Amgen Inc - Yearly Results - Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Net Profit
Dec-2024	33,424	4,090
Dec-2023	28,190	6,717
Dec-2022	26,323	6,552
Dec-2021	25,979	5,893
Dec-2020	25,424	7,264
Dec-2019	23,362	7,842
Dec-2018	23,747	8,394
Dec-2017	22,849	1,979
Dec-2016	22,991	7,722

Balance Sheet Summary

Amgen Inc - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2024	91,839	85,962	5,877
Dec-2023	97,154	90,922	6,232
Dec-2022	65,121	61,460	3,661
Dec-2021	61,165	54,465	6.700
Dec-2020	62,948	53,539	9,409
Dec-2019	59,707	50,034	9,673
Dec-2018	66,416	53,916	12,500
Dec-2017	79,954	54,713	25,241
Dec-2016	77,626	47,751	29,875

Founded Year

1980

Institutional Investors

Top 25 Institutional Investors in AMGEN as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	09/30/2023	4,90,35,981	1,65,636	0.34%	$13,388,294
2	BLACKROCK INC.	09/30/2023	4,75,74,884	6,20,831	1.32%	$12,989,371
3	STATE STREET CORP	09/30/2023	2,85,75,487	-5,23,394	-1.80%	$7,801,965
4	PRIMECAP MANAGEMENT CO/CA/	09/30/2023	1,47,32,458	-3,977	-0.03%	$4,022,403
5	MORGAN STANLEY	09/30/2023	1,32,47,973	-3,52,016	-2.59%	$3,617,094
6	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	1,21,37,491	3,38,308	2.87%	$3,313,899
7	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	1,08,93,895	-3,47,963	-3.10%	$2,974,360
8	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	84,93,209	-10,76,582	-11.25%	$2,318,901
9	WELLS FARGO & COMPANY/MN	09/30/2023	75,81,419	-89,294	-1.16%	$2,069,955
10	NORTHERN TRUST CORP	09/30/2023	69,77,625	2,55,463	3.80%	$1,905,101
11	PRICE T ROWE ASSOCIATES INC /MD/	09/30/2023	63,20,990	14,80,001	30.57%	$1,725,820
12	BANK OF NEW YORK MELLON CORP	09/30/2023	54,37,182	61,528	1.15%	$1,484,514
13	NORGES BANK	12/31/2022	51,46,885	3,51,341	7.33%	$1,405,254
14	ROYAL BANK OF CANADA	09/30/2023	50,79,677	5,18,689	11.37%	$1,386,904
15	JPMORGAN CHASE & CO	09/30/2023	50,31,749	-73,857	-1.45%	$1,373,818
16	ARISTOTLE CAPITAL MANAGEMENT, LLC	09/30/2023	43,53,169	-1,43,898	-3.20%	$1,188,546
17	BANK OF AMERICA CORP /DE/	09/30/2023	41,88,285	-2,24,940	-5.10%	$1,143,527
18	LEGAL & GENERAL GROUP PLC	09/30/2023	40,60,618	-1,52,947	-3.63%	$1,108,671
19	FMR LLC	09/30/2023	36,38,551	-3,04,584	-7.72%	$993,434
20	GOLDMAN SACHS GROUP INC	09/30/2023	35,66,448	6,75,328	23.36%	$973,747
21	INVESCO LTD.	09/30/2023	33,56,359	4,59,340	15.86%	$916,387
22	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	33,05,650	-2,775	-0.08%	$902,542
23	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	30,48,953	-1,03,990	-3.30%	$832,456
24	AMUNDI	09/30/2023	29,57,165	1,91,485	6.92%	$807,395
25	UBS GROUP AG	09/30/2023	29,16,520	-3,34,740	-10.30%	$796,297
26	DEUTSCHE BANK AG\	09/30/2023	28,21,200	-5,23,691	-15.66%	$770,272
27	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	09/30/2023	28,01,331	0	0%	$764,847
28	FEDERATED HERMES, INC.	09/30/2023	24,99,644	26,045	1.05%	$682,478
29	DIMENSIONAL FUND ADVISORS LP	09/30/2023	24,13,126	20,674	0.86%	$658,856
30	CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	09/30/2023	22,25,549	45,384	2.08%	$607,642